Company Profile
Enlivex Therapeutics Stock Price, News & Analysis
- Ticker:
- ENLV
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- United States
Stock performance
6.67 USD (-2.77%)
Close
Last updated: July 13, 2026 at 00:00
115.47M USD
Market cap
Why the stock is moving
ENLV is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Enlivex Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Enlivex Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Enlivex Therapeutics follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Enlivex Therapeutics sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
ZBH · Source: Zimmer Biomet
- 02
- 03
- 04
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
ZBH · Source: Zimmer Biomet
- 05
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
BMY · Source: BMYBristol-Myers Squibb Company
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Enlivex Therapeutics (ENLV)?
Enlivex Therapeutics (ENLV) most recently closed at 6.67 USD, a -2.77% move versus the previous session.
What is the market cap of Enlivex Therapeutics (ENLV)?
Enlivex Therapeutics currently has a market capitalization of 115.47M USD on BioPharmSignal.
What does Enlivex Therapeutics do?
Enlivex Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is ENLV stock listed?
Enlivex Therapeutics (ENLV) is associated with NASDAQ, United States, Biotechnology.
What is Enlivex?
Enlivex Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Enlivex Therapeutics targeting with Enlivex?
Enlivex Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Therapeutics?
Enlivex Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.